Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
Login | Create an Account

Evidence-Based Drug Therapy Update 2020 - (MUSC, Charleston)


Evidence-Based Drug Therapy Update
Hosted by the Medical University of South Carolina
 
Thursday October 29 - Friday October 30, 2020
 
UPDATE: This conference is now an ALL-VIRTUAL meeting.
 

BROCHURE AND LEARNING OBJECTIVES:  Click here to view.  Details for each session may also be found by expanding each session below.

 
REGISTRATION:
Online: click here! To learn more about this activity click here.
By Mail:  Mail registration form (found on page seven of the brochure - click here) 
Email:  cmeoffice@musc.edu – Must include Registration Form
Telephone: (843) 876-1925   – Registration by credit card only
Fax: (843) 876-1931 – Registration by credit card only

Date: Oct 29, 2020 07:15 AM - Oct 30, 2020 05:00 PM

CE Hours

14.00

CE Units

1.400

Activity Type

  • Knowledge-Based and Application-Based

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Medical University of South Carolina

Requirements for CE Credit

To claim credit for a session, participants must sign-in at and attend the entire session.  Participants must complete online evaluations (providing their correct NABP e-profile number and day/month of birth) in order to have credit reported to the NABP CPE Monitor.  Evaluations should be completed and credit claimed within 30 days of the live program to ensure transmission to the NABP CPE Monitor.  The NABP CPE Monitor will not accept any credit claimed and transmitted greater than 60 days from the date of the live program.
 
To verify your NABP e-Profile number and day/month of birth on record with NABP, please visit their website by selecting the link below.

 

 

 

 

 
At the completion of this activity, the participant will be able to:
  1. Determine if an asthma diagnosis is evidence-based
  2. Establish asthma disease severity by guideline definitions
  3. Compare the alternatives of LABA/ICS to albuterol for recommended daily care in patients with mild intermittent asthma

Speaker(s)/Author(s)

Charles Strange, MD
Professor, Division of Pulmonary and Critical Care, Department of Medicine, Medical University of South Carolina

Activity Number

0062-9999-20-138-L01-P
Date: 10/29/20
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Summarize the most recent findings of the sodium glucose cotransport 2 (SGLT2) inhibitors in the management of heart failure
  2. Describe the limitations of the TOPCAT trial
  3. Discuss the current controversies surrounding heart failure with a preserved ejection fraction (HFpEF)
  4. Develop a rational therapeutic plan to achieve specific patient outcomes given a patient case scenario

Speaker(s)/Author(s)

Jean Nappi, PharmD, FCCP
Professor of Clinical Pharmacy and Outcome Sciences, College of Pharmacy, Medical University of South Carolina

Activity Number

0062-9999-20-143-L01-P
Date: 10/29/20
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1.  Participate meaningfully in a shared decision-making discussion with patients regarding hormone replacement therapy, including indications, risks and benefits relative to the patient’s goals of treatment and unique history

Speaker(s)/Author(s)

Jennifer Bain, MD
Associate Professor, Clinical Services Director; Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-20-140-L01-P
Date: 10/29/20
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Review classes of anti-constipation medications
  2. Formulate a treatment plan for patients with constipation

Speaker(s)/Author(s)

Ruth Weber, MD
Clinical Associate Professor, MUSC Department of Family Medicine and Trident Family Medicine Residency, Medical University of South Carolina

Activity Number

0062-9999-20-141-L01-P
Date: 10/29/20
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Interpret the markers of chronic kidney disease and identify when to refer a patient to nephrology
  2. Manage chronic kidney disease up until renal replacement therapy
  3. Explain the role of SGLT2 inhibitors as part of chronic kidney disease management
  4. Discuss new oral potassium removal medicines
  5. Discuss vaptans and polycystic kidney disease

Speaker(s)/Author(s)

Natalie Freidin, MD
Clinical Assistant Professor and Associate Fellowship Program Director, College of Medicine, Division of Nephrology, Medical University of South Carolina

Activity Number

0062-9999-20-142-L01-P
Date: 10/29/20
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Identify patient-specific risk-enhancing factors that would indicate a patient’s need for statin therapy
  2. Incorporate the updated goals for LDL-C levels into current practice models
  3. Utilize non-statin pharmacotherapy options for certain patients
  4. Examine the supporting evidence responsible for the updated guidelines

Speaker(s)/Author(s)

Michael Corvino, PharmD, CDE
Adjunct Assistant Professor, CSU Physician Assistant Program; Clinical Pharmacist, Fetter Health Care Network; Diabetes Educator, Palmetto Pharmacist Network, Fetter Health Care Network

Activity Number

0062-9999-20-150-L01-P
Date: 10/29/20
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Implement the updated CDC Immunization recommendations
  2. Discuss the new drug therapy guidelines for patients and the evidence on which they are based, and how to apply them in selected patients
  3. Describe the current information concerning newly FDA approved medications (pharmacology, pharmacokinetics, efficacy and safety data, drug interactions, dosing, monitoring, and cost) in the selection of evidence-based pharmacotherapy

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, FASHP, FAPhA
Professor Emeritus Department of Clinical Pharmacy and Outcome Sciences and Professor of Family Medicine, MUSC College of Pharmacy

Activity Number

0062-9999-20-148-L01-P
Date: 10/29/20
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 

 

 

At the completion of this activity, the participant will be able to:
  1. Discuss the importance of systolic blood pressure vs. diastolic blood pressure in the risk of cardiovascular events and the benefits of blood pressure lowering and what are the best goal BP levels given the evidence from ACCOMPLISH Trial, Kaiser Permanente data and the Sprint Trial
  2. Describe the current evidence-based strategies for the management of patients with hypertension including the  AHA/ACC 2017 BP Guidelines, the UK-NICE evidence-based guidelines and the AHA Scientific Statement on Resistant Hypertension
  3. Describe the data that the various guidelines used in deciding upon the compelling indications for specific antihypertensive agents in treating selected patients

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, FASHP, FAPhA
Professor Emeritus Department of Clinical Pharmacy and Outcome Sciences and Professor of Family Medicine, MUSC College of Pharmacy

Activity Number

0062-9999-20-145-L01-P
Date: 10/30/20
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Identify contributing risk factors and barriers for treating acute and chronic pain
  2. Identify and diagnose different physiologic types of pain
  3. Apply non opioid treatment options for different types of pain
  4. Compare effectiveness of pain management techniques
  5. Discuss the different treatments for chronic pain syndromes

Speaker(s)/Author(s)

Alec DeCastro, MD
Associate Professor and CAQ Sports Medicine Program Director, Trident/MUSC Family Medicine Residency Program; MUSC Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-20-146-L08-P
Date: 10/30/20
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Discuss treatment considerations in migraine
  2. Describe pathophysiology of migraine yesterday and today

Speaker(s)/Author(s)

Aljoeson Walker, MD
Associate Professor and Neurology and Ophthalmology Director, General Neurology Division Medical University of South Carolina

Activity Number

0062-9999-20-147-L01-P
Date: 10/30/20
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Utilize the latest research to create a patient centered treatment plan for type 2 diabetes
  2. Educate patients on risks and benefits of medications for type 2 diabetes
  3. Navigate the challenges of treatment cost

Speaker(s)/Author(s)

Kristen Hood Watson, MD
Assistant Dean for Resident Inclusion, Assistant Professor, Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-20-144-L01-P
Date: 10/30/20
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to: 
  1. Provide evidence-based information and recommendations on vaping to patients and colleagues in a medical setting

Speaker(s)/Author(s)

Tracy Smith, PhD
Assistant Professor and Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina and Hollings Cancer Center

Activity Number

0062-9999-20-149-L01-P
Date: 10/30/20
Time: 01:45 PM - 02:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Identify the role for non-insulin treatments in patients with type 1 diabetes
  2. Recall goals for continuous glucose monitoring in patients using insulin
  3. Make insulin dosing adjustments as needed for patients

Speaker(s)/Author(s)

Scott Bragg, PharmD, BCPS
Associate Professor, College of Pharmacy and Department of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-20-139-L01-P
Date: 10/30/20
Time: 02:45 PM - 03:45 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Provide evidence-based information and treatment options on coronavirus, influenza and other common infectious diseases

Speaker(s)/Author(s)

Robert Ball, MD, MPH, FACP
Assistant Adjunct Professor, Division of Infectious Disease Department of Medicine Department of Public Health, Medical University of South Carolina

Activity Number

0062-9999-20-151-L01-P
Date: 10/30/20
Time: 04:00 PM - 05:00 PM

CE Hours

1.00
 



 
University of South Carolina College of Pharmacy | 715 Sumter Street, Coker Life Sciences, Columbia, SC 29208 | 803-777-9979 | CE@cop.sc.edu
 
Powered By: Learning ExpressCE
Copyright © 2024 UofSC College of Pharmacy Continuing Education. All Rights Reserved.
About Us Privacy Policy Terms of Service